[PHARMA] QoQ TTM Result on 31-Dec-2011 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Dec-2011 [#4]
Profit Trend
QoQ- 37.4%
YoY- 71.66%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 1,697,728 1,642,700 1,582,398 1,520,981 1,529,311 1,492,216 1,446,116 11.25%
PBT 115,434 102,587 94,349 73,186 54,117 53,876 54,823 64.05%
Tax -32,578 -34,308 -28,102 -20,401 -15,466 -17,749 -18,223 47.14%
NP 82,856 68,279 66,247 52,785 38,651 36,127 36,600 72.15%
-
NP to SH 81,587 67,151 65,358 52,157 37,959 35,734 36,561 70.51%
-
Tax Rate 28.22% 33.44% 29.79% 27.88% 28.58% 32.94% 33.24% -
Total Cost 1,614,872 1,574,421 1,516,151 1,468,196 1,490,660 1,456,089 1,409,516 9.46%
-
Net Worth 496,469 481,394 474,161 514,153 464,092 451,517 437,661 8.74%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 64,713 52,948 44,120 35,296 - - 50,261 18.29%
Div Payout % 79.32% 78.85% 67.51% 67.67% - - 137.47% -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 496,469 481,394 474,161 514,153 464,092 451,517 437,661 8.74%
NOSH 117,646 117,700 117,657 117,655 106,933 106,994 107,007 6.50%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 4.88% 4.16% 4.19% 3.47% 2.53% 2.42% 2.53% -
ROE 16.43% 13.95% 13.78% 10.14% 8.18% 7.91% 8.35% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 1,443.07 1,395.66 1,344.91 1,292.74 1,430.15 1,394.66 1,351.41 4.45%
EPS 69.35 57.05 55.55 44.33 35.50 33.40 34.17 60.09%
DPS 55.00 44.99 37.50 30.00 0.00 0.00 47.00 11.01%
NAPS 4.22 4.09 4.03 4.37 4.34 4.22 4.09 2.10%
Adjusted Per Share Value based on latest NOSH - 117,655
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 117.80 113.98 109.80 105.53 106.11 103.54 100.34 11.25%
EPS 5.66 4.66 4.53 3.62 2.63 2.48 2.54 70.35%
DPS 4.49 3.67 3.06 2.45 0.00 0.00 3.49 18.23%
NAPS 0.3445 0.334 0.329 0.3567 0.322 0.3133 0.3037 8.74%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 7.55 10.18 5.90 5.36 5.90 5.90 5.73 -
P/RPS 0.52 0.73 0.44 0.41 0.41 0.42 0.42 15.25%
P/EPS 10.89 17.84 10.62 12.09 16.62 17.67 16.77 -24.95%
EY 9.19 5.60 9.42 8.27 6.02 5.66 5.96 33.36%
DY 7.28 4.42 6.36 5.60 0.00 0.00 8.20 -7.60%
P/NAPS 1.79 2.49 1.46 1.23 1.36 1.40 1.40 17.74%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 -
Price 8.25 8.83 5.90 5.90 5.90 5.90 5.05 -
P/RPS 0.57 0.63 0.44 0.46 0.41 0.42 0.37 33.28%
P/EPS 11.90 15.48 10.62 13.31 16.62 17.67 14.78 -13.41%
EY 8.41 6.46 9.42 7.51 6.02 5.66 6.77 15.51%
DY 6.67 5.09 6.36 5.08 0.00 0.00 9.31 -19.88%
P/NAPS 1.95 2.16 1.46 1.35 1.36 1.40 1.23 35.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment